IOL Chemicals & Pharmaceuticals
IOLCPNSE

IOL Chemicals & Pharmaceuticals

₹131.425.55 (4.41%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
123.97
Today’s high
132.00
52 week low
67.19
52 week high
138.90
Open price
124.98
Previous close
125.87
Live volume
27,02,119
Lower circuit
105.14
Upper circuit
157.70

Fundamentals

Market Cap
₹3,696Cr
ROE
7.65%
P/E Ratio(TTM)
26.84
EPS(TTM)
4.69
P/B Ratio
2.05
Dividend Yield
0.79%
Industry P/E
33.73
Book Value
61.27
Debt to Equity
0.08
Face Value
2

Financial performance

Quarterly
Yearly
All Financials
MAR '26
Revenue (Cr)
₹621
+6.08%
Profit (Cr)
₹53.16
+158.31%
0200400600800
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Revenue growthValue
1Y (TTM)+17%
3Y CAGR-2%
Profit growthValue
1Y (TTM)+69%
3Y CAGR-16%

About

IOL Chemicals & Pharmaceuticals is a leading global company that manufactures Active Pharmaceutical Ingredients (APIs), Intermediates, and Specialty Chemicals, aiming for excellence and innovation. The company's growth strategy focuses on expanding its non-Ibuprofen API product range, aiming for high-demand areas that provide better outcomes for patients. A central part of its mission is to empower healthier lives worldwide by creating the essential components for medications, making them more affordable and accessible. The company has created a strong position in the API market by supplying ingredients for pain management, anti-diabetic, and anti-convulsant drugs. It is the only company globally with full backward integration for Ibuprofen, controlling every manufacturing step from key starting materials to the final product. Besides being a world leader in Ibuprofen, it is also the second-largest global producer of Iso Butyl Benzene (IBB), with about 30% market share.;
CEO/MD
Varinder Gupta
Founded in
1986
NSE symbol
IOLCP

Shareholding Pattern

Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Promoters
57.48%
Retail And Others
40.78%
Foreign Institutions
1.72%
Mutual Funds
0.02%
Livesquawk
IOL Chemicals Q4 EBITDA rises to ₹925M from ₹630M YoY. EBITDA margin improves to 14.9% vs 11.9% YoY.
2026
20
May
Quarterly & Annual Result
Release date

17
Feb
Dividend
Ex date
₹1.00
per share

For each share you hold, you will receive ₹1.00
Dividend amount₹1.00 per share
Dividend TypeInterim
Ex Date17 Feb ‘26
Record Date17 Feb ‘26
Announcement date11 Feb ‘26

11
Feb
Dividend
Announced
₹1.00
per share

For each share you hold, you will receive ₹1.00
Dividend amount₹1.00 per share
Dividend TypeInterim
Ex Date17 Feb ‘26
Record Date17 Feb ‘26
Announcement date11 Feb ‘26
11
Feb
Quarterly Result
Release date
2025
11
Nov
Quarterly Result
Release date
7
Aug
Quarterly Result
Release date

11
Mar
Split
Ex date
2:10
Ratio

For each share you hold, you will receive 5 shares with face value of ₹2.0 each
Split Ratio2:10
Ex date11 Mar ‘25
Record date11 Mar ‘25
Announcement date27 Dec ‘24

18
Feb
Dividend
Ex date
₹4.00
per share

For each share you hold, you will receive ₹4.00
Dividend amount₹4.00 per share
Dividend TypeInterim
Ex Date18 Feb ‘25
Record Date18 Feb ‘25
Announcement date12 Feb ‘25

12
Feb
Dividend
Announced
₹4.00
per share

For each share you hold, you will receive ₹4.00
Dividend amount₹4.00 per share
Dividend TypeInterim
Ex Date18 Feb ‘25
Record Date18 Feb ‘25
Announcement date12 Feb ‘25
2024

27
Dec
Split
Announced
2:10
Ratio

For each share you hold, you will receive 5 shares with face value of ₹2.0 each
Split Ratio2:10
Ex date11 Mar ‘25
Record date11 Mar ‘25
Announcement date27 Dec ‘24
Events calendar
View upcoming events in other stocks